BioCentury

7:00 AM GMT, Jul 27, 2015
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Lorediplon: Phase IIa started

Ferrer began a double-blind, placebo-controlled, crossover, international Phase IIa trial to compare 5 and 10 mg

Read the full 160 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.